Of the biomarkers under study, growth/differentiation factor-15 (GDF-15), Galectin-3 (Gal-3), and soluble suppression of tumorigenicity 2 (sST-2) stand out as potential key markers for cardiovascular disease (CVD) and its outcomes, possibly offering insights into the cardiac structure [3]. The gene discussed is LGALS3; the disease is cardiovascular disorder.